WFH Guidelines for the Management of Hemophilia, 3rd edition
2020 · Haemophilia · 1,811 citations
https://doi.org/10.1111/hae.14046
E
Elena Santagostino
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
377
Papers
15.1K
Citations
61
h-index
208
i10-index
Elena Santagostino is an academic researcher. The author has contributed to research in topics: Hemophilia Treatment and Research & Platelet Disorders and Treatments & Blood Coagulation and Thrombosis Mechanisms. The author has an h-index of 61, co-authored 321 publications.
ORCID: 0000-0001-9639-6422Papers by this author
worksFactor VIII gene (F8) mutation and risk of inhibitor development in nonsevere hemophilia A
2013 · Blood · 214 citations
https://doi.org/10.1182/blood-2013-02-483263
Inhibitor development and mortality in non‐severe hemophilia A
2015 · Journal of Thrombosis and Haemostasis · 74 citations
https://doi.org/10.1111/jth.12990
Changes in the amino acid sequence of the recombinant human factor VIIa analog, vatreptacog alfa, are associated with clinical immunogenicity
2015 · Journal of Thrombosis and Haemostasis · 59 citations
https://doi.org/10.1111/jth.13141
Desmopressin in moderate hemophilia A patients: a treatment worth considering
2018 · Haematologica · 32 citations
https://doi.org/10.3324/haematol.2017.180059
Risk Factors for the Progression from Low to High Titres in 260 Children with Severe Haemophilia A and Newly Developed Inhibitors
2017 · Thrombosis and Haemostasis · 16 citations
https://doi.org/10.1160/th17-01-0059
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat